Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
3
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
startups
alder biopharmaceutical
allergan
alnylam
american academy of neurology
amgen
antisense oligonucleotide
arena pharmaceuticals
artie suckow
atogepant
benzodiazepines
biogen
biohaven
blackstone group
blackstone life sciences
bob azelby
boston
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
columbia university
david goldstein
depression
detroit blog main
detroit top stories
drug delivery
drugs
What
drugs
3
×
new
3
×
medicines
neuro
advance
aims
approval
arguments
backed
big
biologics
cause
ceo
class
commercialized
companies
competitors
considered
decades
deliver
diseases
drug
dtx
epilepsy
fda
genes
genetic
hitting
links
make
marcio
meeting
migraine
molecules
mutations
nucleic
oral
pharma
potential
praxis
Language
unset
Current search:
xconomy.com
×
drugs
×
new
×
" clinical trials "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
